The Addition of Sirolimus to GVHD Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Efficacy and Safety

OBJECTIVE: The objective of this study was to evaluate the safety and efficacy of sirolimus (SRL) in the prevention of graft-versus-host disease (GVHD) in recipients following allogeneic hematopoietic stem cell transplantation (allo-HSCT). METHODS: Randomized controlled trials (RCTs) evaluating the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaoli, Sun, Hengrui, Cassady, Kaniel, Yang, Shijie, Chen, Ting, Wang, Li, Yan, Hongju, Zhang, Xi, Feng, Yimei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458935/
https://www.ncbi.nlm.nih.gov/pubmed/34568015
http://dx.doi.org/10.3389/fonc.2021.683263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458935/
https://www.ncbi.nlm.nih.gov/pubmed/34568015
http://dx.doi.org/10.3389/fonc.2021.683263

Ejemplares similares